120 related articles for article (PubMed ID: 21750437)
1. Is there an optimal combination of antihypertensives for preventing cardiovascular events?
Teo KK
J Hypertens; 2011 Aug; 29(8):1483-5. PubMed ID: 21750437
[No Abstract] [Full Text] [Related]
2. [COPE trial].
Umemoto S; Kamiya A; Matsuzaki M; Ogihara T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():470-4. PubMed ID: 16981580
[No Abstract] [Full Text] [Related]
3. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.
Matsuzaki M; Ogihara T; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Abe K; Suzuki N; Eto T; Higaki J; Ito S; Kamiya A; Kikuchi K; Suzuki H; Tei C; Ohashi Y; Saruta T;
J Hypertens; 2011 Aug; 29(8):1649-59. PubMed ID: 21610513
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
[TBL] [Abstract][Full Text] [Related]
5. A compendium of antihypertensive therapy.
Ferdinand KC
J Clin Hypertens (Greenwich); 2011 Sep; 13(9):636-8. PubMed ID: 21896141
[No Abstract] [Full Text] [Related]
6. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
Browne GA; Griffin TP; O'Shea PM; Dennedy MC
Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
[TBL] [Abstract][Full Text] [Related]
7. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.
Kato J; Yokota N; Tamaki N; Kariya S; Kita T; Ayabe T; Eto T; Kitamura K
Hypertens Res; 2011 Mar; 34(3):331-5. PubMed ID: 21124326
[TBL] [Abstract][Full Text] [Related]
8. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
Brown A; Captain B
Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
[TBL] [Abstract][Full Text] [Related]
9. The drug treatment of hypertension--the place of calcium antagonists.
Louis WJ; McNeil JJ
Br J Clin Pract Suppl; 1985 Jun; 42():27-33. PubMed ID: 2864074
[No Abstract] [Full Text] [Related]
10. Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial.
Rakugi H; Ogihara T; Umemoto S; Matsuzaki M; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2013 Nov; 36(11):947-58. PubMed ID: 23864054
[TBL] [Abstract][Full Text] [Related]
11. [Hypertension therapies compared. Are the new nevertheless better than the old?].
MMW Fortschr Med; 2005 Mar; 147(12):6, 8. PubMed ID: 15832780
[No Abstract] [Full Text] [Related]
12. Beta-blockers in the treatment of hypertension: latest data and opinions.
Tsalta D; Anastasakis E; Papadogiannis DE
Hellenic J Cardiol; 2008; 49(1):37-47. PubMed ID: 18350781
[No Abstract] [Full Text] [Related]
13. Clinical inquiries. What is the best regimen for newly diagnosed hypertension?
Saseen JJ; Turner C; Russell RG
J Fam Pract; 2005 Mar; 54(3):281-2. PubMed ID: 15755386
[No Abstract] [Full Text] [Related]
14. ASCOT blood pressure-lowering arm--study of effects of two BP-lowering regimens in hypertensive patients with cardiovascular risk factors.
Cardiovasc J S Afr; 2005; 16(2):124, 126-7. PubMed ID: 15915281
[No Abstract] [Full Text] [Related]
15. Hypertension in the elderly: treatment.
Schulman SP; Gerstenblith G
Cardiol Clin; 1986 May; 4(2):245-52. PubMed ID: 2871936
[TBL] [Abstract][Full Text] [Related]
16. Have ALLHAT, ANBP2, ASCOT-BPLA, and so forth improved our knowledge about better hypertension care?
Sawicki PT; McGauran N
Hypertension; 2006 Jul; 48(1):1-7. PubMed ID: 16735646
[No Abstract] [Full Text] [Related]
17. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
18. The return on INVEST.
Alderman MH
JAMA; 2003 Dec; 290(21):2859-61. PubMed ID: 14657071
[No Abstract] [Full Text] [Related]
19. Clinical challenges in diagnosing and managing adult hypertension.
Handler J
Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S36-41. PubMed ID: 26694890
[TBL] [Abstract][Full Text] [Related]
20. Initial therapy of hypertension.
Med Lett Drugs Ther; 2004 Jul; 46(1186):53-5. PubMed ID: 15237281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
